Loading chat...
MN HF4265
Bill
Status
3/14/2022
Primary Sponsor
Liz Olson
Click for details
AI Summary
-
Municipalities are barred from asserting, filing, or enforcing claims against settling defendants (Johnson & Johnson, AmerisourceBergen, Cardinal Health, McKesson) that have been released in statewide opioid settlement agreements; the attorney general may intervene to release such claims with prejudice.
-
Establishes two accounts within the opiate epidemic response fund: a registration and license fee account and a settlement account to receive opioid settlement proceeds from the state attorney general's litigation and settlements.
-
Opioid settlement proceeds deposited into the settlement account are appropriated to the commissioner of human services for grants as specified by the Opiate Epidemic Response Advisory Council, with funds also directed to Tribal social service agency initiatives and child protection services.
-
Modifies the timeline for reducing opioid manufacturer registration fees and license fees from July 1, 2024, to July 1, 2031, contingent on the state receiving $250 million from opioid settlements and fees combined; when reached, license fees reduce to $5,260 and the registration fee is repealed.
-
Transfers money from a separate opioid settlement account in the state treasury to the settlement account in the opiate epidemic response fund and eliminates the separate account.
Legislative Description
Opioid settlement proceed deposit and allocation provided, two accounts established in the opiate epidemic response fund, separate opioid account in the state treasury eliminated, time frame modified for eliminating the opioid manufacturer registration fee and reducing license fees, and municipal claims barred against litigants in settled opioid cases.
Last Action
Second reading
4/7/2022